Skip to content
Buy This GLP
← Research
Safety

Can a GLP-1 Cause a Skin Rash? What Wegovy Trials Show

Wegovy trials reported injection site reactions in adults and rash and hives in adolescents. Learn when to seek help for a possible allergic reaction.

Editorial profile: Neil SandersBuy This GLP Editorial Team4 min read
Wegovy injection weight-loss trialsWegovyPlaceboAdult injection site reactions1.4%1%Pediatric rash3%0%Pediatric hives3%0%

A rash or a reaction where you inject can occur with GLP-1 medicines. In adult weight-loss trials of Wegovy injection, 1.4% of treated patients and 1% of placebo patients had injection site reactions. That figure covers local reactions such as itching, redness and irritation [1].

What Wegovy trials and labeling report

Our GLP-1 side-effect guide puts local symptoms in context alongside common effects like nausea. A local reaction can include redness, itching, swelling or firm skin at the injection site. In the pediatric Wegovy injection weight-loss trial, rash and hives were each reported in 3% of treated patients and 0% of placebo patients [1].

If you develop a new rash without emergency symptoms, contact your prescriber for advice. Wegovy’s label lists a prior serious allergic reaction to semaglutide or any ingredient in Wegovy as a contraindication [1].

What FDA adverse event reports can show

Our guide to FDA adverse event reports explains how these reports help identify possible safety signals. In a 2018–2024 analysis of four GLP-1 medicines, skin-related events accounted for 8.16% of the semaglutide reports and 5.75% across the four medicines. The category included symptoms other than rash, such as itching and hair loss [2].

Skin events made up a smaller share of GLP-1 reports than of reports about DPP-4 inhibitors in that analysis (proportional reporting ratio 0.27, 95% confidence interval 0.257–0.284). Those are proportions among submitted reports. They cannot tell us how often patients experience these reactions or which medicine is safer for a particular person [2].

Clinicians have published individual cases of suspected hypersensitivity and fixed drug eruption after semaglutide use. These reports describe what can prompt evaluation, but cannot establish how often those reactions happen[3] [4].

Frequently asked

Can Wegovy cause a rash?
In one pediatric trial, 3% of patients treated with Wegovy injection and none on placebo reported a rash. Adult injection site reactions were reported in 1.4% on Wegovy and 1% on placebo.
When does a possible allergic reaction need urgent attention?
The Wegovy Medication Guide says to stop using it and get medical help right away for serious symptoms such as swelling of the face, mouth or throat, trouble breathing or swallowing, or a severe rash.

Sources

  1. [1] Novo Nordisk (2026). WEGOVY (semaglutide) — prescribing information DailyMed, U.S. National Library of Medicine. Source
  2. [2] Fat MN, Johnson HC, Farberg AS (2026). Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024 Journal of Drugs in Dermatology. PMID 41493256
  3. [3] Ouellette S, Frias G, Shah R, et al. (2023). Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports Journal of Drugs in Dermatology. Source
  4. [4] Talasila S, Waseh S, Liu JY, et al. (2025). Semaglutide-induced fixed drug eruption JAAD Case Reports. Source

More in Safety